Source:http://linkedlifedata.com/resource/pubmed/id/11756349
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2001-12-28
|
pubmed:abstractText |
Variation in the calpain-10 gene (CAPN10) has been shown to be associated with type 2 diabetes in Mexican-Americans and in at least three Northern European populations. Studies in nondiabetic Pima Indians showed that one of the at-risk DNA polymorphisms, single-nucleotide polymorphism (SNP)-43, in CAPN10 was associated with insulin resistance, and individuals with the G/G-genotype had significantly higher fasting plasma glucose and 2-h insulin concentrations after a 75-g oral glucose tolerance test (OGTT). We have examined the effect of variation in CAPN10 on plasma glucose and insulin levels in a group of 285 nondiabetic British subjects after a 75-g OGTT. The results showed that subjects with G/G genotype at SNP-43 had higher 2-h plasma glucose levels than the combined G/A + A/A group (P = 0.05). We also examined the SNP-43, -19, and -63 haplotype combination 112/121, which is associated with an approximately threefold increased risk of diabetes. Subjects with the 112/121 haplotype combination (n = 29) had increased fasting (P = 0.004) and 2-h plasma glucose levels (P = 0.003) compared with the rest of the study population after correction for age, sex, and BMI. The 112/121 haplotype combination was also associated with a marked decrease in the insulin secretory response, adjusted for the level of insulin resistance (P = 0.002). We conclude that genetic variation in the CAPN10 gene influences blood glucose levels in nondiabetic British subjects and that this is due, at least in part, to the effects of calpain-10 on the early insulin secretory response.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0012-1797
|
pubmed:author |
pubmed-author:BellGraeme IGI,
pubmed-author:CoxNancy JNJ,
pubmed-author:EvansJulie CJC,
pubmed-author:FraylingTimothy MTM,
pubmed-author:HattersleyAndrew TAT,
pubmed-author:HorikawaYukioY,
pubmed-author:LynnStephenS,
pubmed-author:TurnbullDoug MDM,
pubmed-author:WalkerMarkM,
pubmed-author:WhiteChristopherC
|
pubmed:issnType |
Print
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
247-50
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11756349-Adult,
pubmed-meshheading:11756349-Aged,
pubmed-meshheading:11756349-Blood Glucose,
pubmed-meshheading:11756349-Body Constitution,
pubmed-meshheading:11756349-Body Mass Index,
pubmed-meshheading:11756349-Calpain,
pubmed-meshheading:11756349-European Continental Ancestry Group,
pubmed-meshheading:11756349-Female,
pubmed-meshheading:11756349-Genetic Variation,
pubmed-meshheading:11756349-Glucose Tolerance Test,
pubmed-meshheading:11756349-Great Britain,
pubmed-meshheading:11756349-Humans,
pubmed-meshheading:11756349-Insulin,
pubmed-meshheading:11756349-Ireland,
pubmed-meshheading:11756349-Male,
pubmed-meshheading:11756349-Middle Aged,
pubmed-meshheading:11756349-Polymerase Chain Reaction
|
pubmed:year |
2002
|
pubmed:articleTitle |
Variation in the calpain-10 gene affects blood glucose levels in the British population.
|
pubmed:affiliation |
School of Clinical Medical Sciences, the Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|